86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,205 /  Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT03229499
(ClinicalTrials.gov)		December 7, 201718/7/2017Pulmonary Hypertension and Anastrozole TrialPulmonary Hypertension and Anastrozole Trial (PHANTOM)Pulmonary Arterial HypertensionDrug: Anastrozole;Drug: Placebo Oral TabletUniversity of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI);Johns Hopkins University;University of Colorado, Denver;Rhode Island Hospital;Stanford University;Vanderbilt University;Washington University School of MedicineCompleted18 YearsN/AAll84Phase 2United States
2NCT01545336
(ClinicalTrials.gov)		October 201229/2/2012Anastrozole in Patients With Pulmonary Arterial HypertensionA Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionDrug: Anastrozole;Drug: PlaceboUniversity of PennsylvaniaNULLCompleted18 YearsN/AAll18Phase 2United States